Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
The Battery Show Europ...The Battery Show Europe
Not Confirmed
Not Confirmed
03-05 June, 2025
Chemspec EuropeChemspec Europe
Not Confirmed
Not Confirmed
04-05 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
The Battery Show Europ...The Battery Show Europe
Industry Trade Show
Not Confirmed
03-05 June, 2025
Chemspec EuropeChemspec Europe
Industry Trade Show
Not Confirmed
04-05 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
28 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250528489524/en/Verastem-Oncology-to-Present-at-the-Jefferies-Global-Healthcare-Conference
22 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250522753974/en/Verastem-Oncology-Announces-Positive-Updated-Results-from-RAMP-205-Evaluating-Avutometinib-Plus-Defactinib-in-Combination-with-Standard-of-Care-Chemotherapy-in-Frontline-Metastatic-Pancreatic-Ductal-Adenocarcinoma
20 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250520003336/en/Tempus-Announces-a-Collaboration-with-Verastem-to-Develop-CDx-for-First-Ever-FDA-Approved-KRAS-Mutant-Recurrent-Low-Grade-Serous-Ovarian-Cancer-Combination-Treatment
13 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250513753037/en/Verastem-Oncology-Reports-First-Quarter-2025-Financial-Results-and-Highlights-Recent-Business-Updates
12 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/12/3079541/0/en/Onco360-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Partner-for-AVMAPKI-FAKZYNJA-CO-PACK.html
09 May 2025
// ENDPTS
https://endpts.com/verastem-wins-first-fda-approval-for-ovarian-cancer-therapy/
ABOUT THIS PAGE